[Federal Register Volume 88, Number 45 (Wednesday, March 8, 2023)]
[Notices]
[Page 14370]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-04698]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP)--RFA-PS23-002, Enhancing Telehealth Strategies To 
Support Retention and Adherence to Antiretroviral Therapy (ART) and 
RFA-PS23-005, Expanding Rapid Initiation of Antiretroviral Therapy in 
Non-Traditional Settings: Emergency Department; Amended Notice of 
Closed Meeting

    Notice is hereby given of a change in the meeting of the Disease, 
Disability, and Injury Prevention and Control Special Emphasis Panel 
(SEP)--RFA-PS23-002, Enhancing Telehealth Strategies to Support 
Retention and Adherence to Antiretroviral Therapy (ART) and RFA-PS23-
005, Expanding Rapid Initiation of Antiretroviral Therapy in Non-
traditional Settings: Emergency Department, May 24-25, 2023, 10 a.m.-5 
p.m., EDT, Teleconference, Centers for Disease Control and Prevention, 
Room 1077, 8 Corporate Blvd., Atlanta, GA 30329, in the original FRN. 
The meeting was published in the Federal Register on February 13, 2023, 
Volume 88, Number 29, page/s/ 9290.
    The meeting is being amended to remove RFA-PS23-005, Expanding 
Rapid Initiation of Antiretroviral Therapy in Non-traditional Settings: 
Emergency Department and replace with RFA-PS23-003, Exploring 
Preferences for Long-Acting Antiretroviral Therapies (LA-ART) in a 
Community-Based Sample of Priority Populations Living with HIV Who are 
Disproportionately Affected and the date the teleconference is has 
changed and should read as follows:
    Date: May 11-12, 2023.
    Time: 10 a.m.-5 p.m. (EDT).
    Place: Teleconference, Centers for Disease Control and Prevention, 
Room 1077, 8 Corporate Blvd., Atlanta, GA 30329.
    The meeting is closed to the public.

FOR FURTHER INFORMATION CONTACT: Gregory Anderson, M.S., M.P.H., 
Scientific Review Officer, National Center for HIV, Viral Hepatitis, 
STD, and TB Prevention, CDC, 1600 Clifton Road NE, Mailstop US8-1, 
Atlanta, Georgia 30329, Telephone: (404) 718-8833; Email: 
[email protected].
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-04698 Filed 3-7-23; 8:45 am]
BILLING CODE 4163-18-P